On the elimination half-life of lithium in long-term treatment of patients with affective disorders
β Scribed by Agneta Nilsson; Rolf Axelsson
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 703 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
β¦ Synopsis
The elimination half-life of lithium was investigated in 55 patients on long-term treatment in 1980, when their mean treatment time was 7.5 years. Twenty-seven of the patients were reinvestigated 7 years later, at which point their mean treatment time was 15 years. An approximate method for determining the elimination half-life of lithium was used, and this variable was tested in eight chronic psychotic patients on lithium treatment, in whom the elimination half-life was also determined by a conventional technique. The elimination half-life was 32 h in 1980 and varied between 15 and 128 h. The elimination half-life was significantly increased 7 years later, with a median increase of 8 h. The elimination half-life of lithium was closely correlated to age and to daily weight-related dose of lithium when the patients entered the study in 1980, but this was not seen at the time of the reinvestigation in 1987. The elimination half-life did not vary with serum creatinine, maximal urine osmolality, or with the concomitant neuroleptic medication. Further studies are needed to clarify the clinical significance of the prolonged elimination half-life with time.
π SIMILAR VOLUMES
Thyroid iodine release measured by the double isotope method of Nicoloff was studied in patients with manic-depressive illness before, during and after treatment with lithium carbonate. The urinary lZSI/ZalI isotope ratio was measured following administration of Nal~SI and z3~I-thyroxine. In three o
More than half of the patients with testicular germ-cell cancer show impaired spermatogenesis before undergoing cytotoxic treatment. The known pre-treatment infertility and the reversibility of the fertility problems observed in some after successful anti-cancer treatment have so far prevented an as
Diffuse coronary lesions (length > 20 mm) are still considered high risk for percutaneous intervention even in the current stent era. We compared the 2-year outcome of patients with long diffuse stenosis treated by three different stent strategies. In addition, we also analyzed the possible factors